Cite
Raoof M, Malhotra G, Kohut A, et al. PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial. Ann Surg Oncol. 2021;29(1):175-185doi: 10.1245/s10434-021-10505-0.
Raoof, M., Malhotra, G., Kohut, A., O'Leary, M., Frankel, P., Tran, T., Fakih, M., Chao, J., Lim, D., Woo, Y., Paz, I. B., Lew, M., Cristea, M. C., Rodriguez-Rodriguez, L., Fong, Y., Blakely, A., Whelan, R., Reymond, M. A., Merchea, A., & Dellinger, T. H. (2022). PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial. Annals of surgical oncology, 29(1), 175-185. https://doi.org/10.1245/s10434-021-10505-0
Raoof, Mustafa, et al. "PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial." Annals of surgical oncology vol. 29,1 (2022): 175-185. doi: https://doi.org/10.1245/s10434-021-10505-0
Raoof M, Malhotra G, Kohut A, O'Leary M, Frankel P, Tran T, Fakih M, Chao J, Lim D, Woo Y, Paz IB, Lew M, Cristea MC, Rodriguez-Rodriguez L, Fong Y, Blakely A, Whelan R, Reymond MA, Merchea A, Dellinger TH. PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial. Ann Surg Oncol. 2022 Jan;29(1):175-185. doi: 10.1245/s10434-021-10505-0. Epub 2021 Aug 13. PMID: 34387765.
Copy
Download .nbib